The itch sensation results from the excitation of primary sensory nerve endings in the skin, but the underlying molecular mechanisms are not completely understood. Liu et al. (2009) now report that some members of the Mrgpr class of G protein-coupled receptors mediate the itch caused by the antimalarial drug chloroquine.
Like good housekeepers, cells spend considerable energy caring for their genetic material, mopping up DNA damage that may alter the reading of their genetic information. The most difficult type of damage to repair, and at the same time the most detrimental, are DNA interstrand crosslinks (ICLs). ICLs block DNA replication, making their removal an essential requirement for cell survival. Defects in ICL repair underlie Fanconi Anemia (FA), and the severe clinical symptoms of the disorder (blood marrow failure, developmental abnormalities, and cancer predisposition, often leading to an early death) testify to the toxicity of ICLs (Moldovan and D'Andrea, 2009; Patel and Joenje, 2007 ). Yet, how the proteins in the FA pathway protect against ICLs has long remained a mystery. Using a cell-free system, Knipscheer et al. (2009) now show that FA proteins are directly involved at several steps in the process of ICL repair.
Removal of ICLs mostly occurs in S phase and involves the stepwise involvement of nucleases, specialized DNA polymerases that bypass lesions, and factors that mediate homologous recombination (Moldovan and D'Andrea, 2009) . In prior work the authors devised an experimental approach to investigate replication-dependent repair of ICLs using a cell-free replication system of egg extracts from the frog Xenopus (Raschle et al., 2008) . Their system reveals that replication forks, converging from both directions, initially stop 20-40 nucleotides from the crosslink (Figure 1) . One of the forks subsequently moves further and stops again just before the crosslink (at position −1). Nucleolytic incisions on both sides of the crosslink, and DNA polymerization across the lesion, restore one of the chromatids, whereas the other chromatid is most likely repaired through homologous recombination. In an elegant application of their crosslink repair system, Knipscheer et al. now show that loss of proteins in the FA pathway can block both the incision and bypass steps.
Thirteen proteins cooperate in the FA pathway. Eight of these proteins form a ubiquitin ligase complex that monoubiquitinates the substrates FANCD2 and FANCI. In the new study, immunodepletion of FANCD2 from the egg extracts (which also codepletes its heterodimeric partner FANCI) dramatically inhibits crosslink repair, demonstrating that FA is a true DNA repair syndrome. Nucleotide insertion opposite the ICL is blocked in the absence of FANCD2, such that the leading strand progresses only to position −1. Also, the two incisions required to unhook the crosslink are not detected in extracts depleted of FANCD2. All defects can be rescued by adding back the recombinant FANCD2-FANCI complex, but not by adding back a complex containing a point mutant of FANCD2 that cannot be ubiquitinated. Accordingly, when the investigators examine the timing of FANCD2 ubiquitination, they find that this modification occurs precisely when the replication fork reaches the −1 position. FANCD2 ubiquitination, known to be essential for crosslink tolerance, is therefore required to advance the replication fork across the crosslink, by orchestrating the unhooking of the crosslink and DNA synthesis across the lesion.
Bypass of DNA lesions is a potentially mutagenic process performed by specialized polymerases. The FA path-Cell 139, December 24, 2009 ©2009 Elsevier Inc. 1223 way is known to be required for mutagenesis, and the polymerase Rev1 is epistatic to FA and may function in FAdependent lesion bypass (Mirchandani et al., 2008; Niedzwiedz et al., 2004) . The finding that FANCD2 ubiquitination promotes crosslink bypass supports a model in which Rev1 is recruited, via its ubiquitin-binding domain, to the ubiquitinated FANCD2 protein. This model is analogous to the recruitment of Y-family polymerases, such as DNA polymerase η, by monoubiquitinated PCNA, which is required for the polymerase to bypass lesions induced by UV light (Bienko et al., 2005) . It should now be possible to test this model for crosslink bypass by depleting Rev1 from egg extracts in this cell-free replication system, and by assessing whether Rev1 and ubiquitinated FANCD2 interact. As human cells have at least 15 polymerases, a different mutagenic polymerase might also be involved. Interestingly, only about 25% of crosslinked plasmids are recovered as repaired, error-free DNA molecules (Knipscheer et al., 2009) , raising the possibility that some sites are repaired with errors. Investigating the mutation spectrum of the repaired templates may help identify the relevant polymerases. Alternatively, FANCD2 may not directly recruit a polymerase but rather stabilize some structure at the crosslink site, thus indirectly allowing a nucleotide insertion event.
How the FANCD2 protein regulates the DNA incisions flanking the crosslink is even more intriguing. FANCD2 has no known enzymatic activity, possesses no obvious nuclease domains, and has no known associated nucleases. Perhaps a cryptic nuclease activity of FANCD2 is activated by monoubiquitination when a replication fork encounters a crosslink. Alternatively, ubiquitinated FANCD2 may transiently recruit some known nuclease complex, such as Mus81-Eme1, Xpf-Ercc1, or the newly described Slx4 complex.
At present, the Xenopus experimental system cannot temporally dissociate the incision and bypass steps. Although it is logical to assume that incision occurs first, allowing bypass by a polymerase such as Rev1, the alternative possibility should not be excluded: nucleotide insertion opposite the ICL may create a DNA structure that promotes incision. Also, it is possible that the proximal incision occurs first, followed by the lesion bypass step and the distal incision. In either case, FANCD2 may only be required for the first activity in the stepwise process. Depletion of FANCD2 may thus only indirectly affect the subsequent steps. Alternatively, FANCD2 may directly activate both incision and bypass, irrespective of their order of occurrence.
Recent studies indicate that the regulated deubiquitination of FANCD2 by the ubiquitin protease complex, USP1/UAF1, is also required for crosslink repair (Moldovan and D'Andrea, 2009). Whether deubiquitination is required for incision or lesion bypass is also unknown. The Xenopus system may be useful in resolving these questions as well.
An apparent shortcoming of this model system is its inability (to date) to decipher the roles of the FA pathway in the last part of the ICL repair process, the step involving homologous recombination. Only the repair of the chromatid with the unhooked crosslink can be investigated, probably due to degradation of the other sister chromatid that is broken by incisions. Therefore, the repair process in this system terminates before the final recombination step. It is possible that FANCD2 plays only an indirect role in this final step, simply handing off the product of the incision and insertion steps to the machinery for homologous recombination. This machinery most likely involves the recombination mediator BRCA2, identified as the FA factor FANCD1 (Howlett et al., 2002) , and its binding partner, FANCN. Alternatively, the FA pathway may be actively involved in homologous Crosslink repair is initiated by stalling of the two replication forks on either side of the interstrand crosslink (ICL). One of the forks subsequently moves to the crosslink site. By the time the fork reaches position −1, FANCD2 has been monoubiquitinated by the Fanconi Anemia (FA) core complex. Ubiquitinated FANCI-FANCD2 then promotes nucleolytic incisions and the unhooking of the crosslink, allowing bypass of the lesion by polymerases. Finally, homologous recombination concludes the repair reaction. Monoubiquitinated FANCD2 may directly activate nucleolytic processes (top inset), recruit translesion synthesis polymerases (bottom inset), or both.
recombination. This possibility is supported by evidence that FANCD2 and FANCI are required for the homologous recombination induced by DNA doublestrand breaks (Moldovan and D'Andrea, 2009) , suggesting a general role of the FA pathway in promoting recombination. It is currently unclear whether this function represents a direct participation of the FA pathway (for example, recruitment of factors that mediate homologous recombination), or a more indirect one, such as inhibition of alternative competing repair pathways (such as the error-prone nonhomologous endjoining pathway).
Despite these shortcomings, Xenopus egg extracts should allow the identification and characterization of the nucleases and polymerases involved in ICL repair and help to elucidate how these activities are controlled by the FA pathway. This knowledge may, over time, lead to better therapeutic strategies for FA patients.
Together with the recently described role of the FA pathway in activating the DNA-damage checkpoint induced by crosslinks (Ben-Yehoyada et al., 2009) , these new findings paint the picture of a dynamic, multifaceted pathway involved in numerous steps in the cellular response to DNA crosslinks. Sensations such as touch, temperature, itch, and pain are mediated by primary somatosensory neurons that detect thermal, mechanical, and chemical cues and relay this information to the central nervous system (Figure 1) . Itch, or pruritus, is defined as the unpleasant sensation that elicits scratching behavior. In this sense, itch is quite distinct from pain, the application of which causes the hasty withdrawal of the affected body part. Nevertheless, pain and itch stimuli can sometimes interact; for instance, a pain sensation can inhibit an itch sensation. It even has been suggested that itch is a form of low-intensity pain. However, accumulating evidence favors the now prevailing view that pain and itch are reported by distinct primary sensory neurons and separate sensory pathways, albeit with overlapping regulatory mechanisms (Ikoma et al., 2006; Paus et al., 2006; Sun et al., 2009) It is well established that some primary sensory neurons express members of a group of closely related receptors belonging to the Mrgpr family. There are ?24 potentially functional Mrgpr genes in mice but, strikingly, only eight in humans (Dong et al., 2001 ). Mrgpr expression is highly restricted to primary sensory neurons, hinting at a somatosensory role. However, their function has remained enigmatic. The new study by Liu et al. (2009) indicates that some of these receptors are involved in an itch sensation that is independent of that mediated by the best known itch inducer, histamine.
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